17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-14-HYDROXY-3-(((TRIFLUOROMETHYL)SULFONYL)OXY)MORPHINAN-6-ONE, (5.ALPHA.)-
UNII EPM767D8JD
Substance Identification & Data
This profile provides standardized clinical and technical data for 17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-3-(((trifluoromethyl)sulfonyl)oxy)morphinan-6-one, (5.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EPM767D8JD.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 205375-23-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H22F3NO6S QSPGSENWVSPIQZ-XFWGSAIBSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-3-(((trifluoromethyl)sulfonyl)oxy)morphinan-6-one, (5.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.